Literature DB >> 2581600

Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.

R Berman, B Gusterson, G G Steel.   

Abstract

Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was a CY induced resistant subline of HX78 and was unstable when maintained without CY exposure. Conventional light microscopy, cytology and electron microscopy examination of the xenografts revealed appearances consistent with SCC. An antikeratin antibody demonstrated the presence of keratin in the inherent and the induced resistant xenografts (and in the unstable revertant) but not in the two sensitive xenografts; the presence of keratin suggested squamous differentiation. Monolayer culture morphology of the sensitive HX78 and the unstable revertant was anchorage independent with the cells forming floating aggregates; the induced resistant subline of this xenograft (HX78Cy) showed, by contrast, flattened, angular adherent cells. Beta HCG production was detected in the monolayer culture supernatant of sensitive HX78 cells; the level of production of beta HCG was increased in the induced resistant HX78Cy cells. Karyotype and flow cytometry studies were also performed. The morphological responses of small cell lung cancer to treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581600      PMCID: PMC1977064          DOI: 10.1038/bjc.1985.98

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Mixed anaplastic small-cell and squamous-cell carcinoma of the lung.

Authors:  H D Brereton; M M Mathews; J Costa; C H Kent; R E Johnson
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

Review 2.  The respiratory epithelium. V. Histogenesis of lung carcinomas in the human.

Authors:  E M McDowell; J S McLaughlin; D K Merenyl; R F Kieffer; C C Harris; B F Trump
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

3.  Simultaneous demonstration of keratin and mucin.

Authors:  D P Mitchell; B A Gusterson
Journal:  J Histochem Cytochem       Date:  1982-07       Impact factor: 2.479

4.  Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis.

Authors:  L L Vindeløv; H H Hansen; A Gersel; F R Hirsch; N I Nissen
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

5.  Tumor marker production in human bronchial carcinoma xenografts.

Authors:  A J Shorthouse; S M Carter; M L Ellison
Journal:  Oncodev Biol Med       Date:  1982

6.  The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison.

Authors:  A J Shorthouse; M J Peckham; J F Smyth; G G Steel
Journal:  Br J Cancer Suppl       Date:  1980-04

7.  Immunohistochemical localisation of keratin in human lung tumours.

Authors:  B Gusterson; D Mitchell; M Warburton; J Sloane
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

8.  Atypical endocrine tumors of the lung.

Authors:  E M McDowell; T S Wilson; B F Trump
Journal:  Arch Pathol Lab Med       Date:  1981-01       Impact factor: 5.534

9.  Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.

Authors:  R Berman; G G Steel
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  9 in total
  1 in total

1.  The role of human chorionic gonadotropin beta subunit elevation in small-cell lung cancer patients.

Authors:  M Szturmowicz; E Wiatr; A Sakowicz; J Slodkowska; K Roszkowski; S Filipecki; E R Rowinska-Zakrzewska
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.